Accel Wealth Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
Accel Wealth Management's RGEN Position: Q4 2021 in Review
Accel Wealth Management sold out of Repligen (RGEN) in Q4 2021, closing a stake of 95 shares — an estimated $27K sold.
Accel Wealth Management first reported a position in RGEN in Q4 2020 and held it in 4 quarters. The position peaked at $29K in Q4 2020. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.
- Accel Wealth Management reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
- Accel Wealth Management sold 95 Repligen shares in Q4 2021, an estimated $27K.
- Accel Wealth Management first reported a position in Repligen in Q4 2020 and held it in 4 quarters.
- Accel Wealth Management's Repligen position peaked at $29K in Q4 2020.
- 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.
Based on Accel Wealth Management's 13F filing for Q4 2021, filed 18 Jan 2022.